Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US firm expands incontinence gel trials:

This article was originally published in Clinica

Executive Summary

Protein Polymer Technologies has added an additional clinical centre to accelerate human testing of its urethral bulking agent for the treatment of female stress urinary incontinence. The product, which is being tested under an investigational device exemption, is injected into the tissues surrounding the sphincter at the base of the bladder where it forms a firm hydrogel to narrow the urethra lumen and prevent urine leakage. The San Diego, California firm expects to launch the product in the US in 2005. The company adds that estimates shows that over $3 billion is spent in the US every year on incontinence-related care.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064863

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel